185 related articles for article (PubMed ID: 6380393)
21. [The course of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion].
Hooymans JM; van Ballegooie E; Reitsma WD; Schweitzer NM
Ned Tijdschr Geneeskd; 1988 Apr; 132(14):624-8. PubMed ID: 3362238
[No Abstract] [Full Text] [Related]
22. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
[TBL] [Abstract][Full Text] [Related]
23. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
Berhe T; Postellon D; Wilson B; Stone R
Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
[TBL] [Abstract][Full Text] [Related]
24. Rediscovery of insulin pump treatment of childhood type 1 diabetes.
Weinzimer SA; Doyle EA; Steffen AT; Sikes KA; Tamborlane WV
Minerva Med; 2004 Apr; 95(2):85-92. PubMed ID: 15272243
[TBL] [Abstract][Full Text] [Related]
25. Current status and future of implantable insulin pumps for the treatment of diabetes.
Catargi B
Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
[TBL] [Abstract][Full Text] [Related]
26. [Effect of octreotide on blood glucose levels in poorly compensated insulin-dependent diabetics on insulin treatment].
Lunetta M; Di Mauro M; Le Moli R
Minerva Endocrinol; 1992; 17(1):7-12. PubMed ID: 1495454
[TBL] [Abstract][Full Text] [Related]
27. [Ambulatory treatment of diabetes in children by continuous subcutaneous infusion of insulin using a portable pump].
Bougnères PF; Landier F; Lemmel C; Golse B; Chaussain JL
Arch Fr Pediatr; 1984 Jan; 41(1):27-33. PubMed ID: 6721650
[TBL] [Abstract][Full Text] [Related]
28. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
[TBL] [Abstract][Full Text] [Related]
29. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
Mozdzan M; Ruxer J; Loba J
Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
[TBL] [Abstract][Full Text] [Related]
30. [Long-term insulin treatment using continuous subcutaneous insulin infusions: metabolic control and hemorheological aspects].
Lombardo A; Scornavacca G; Scavino S; Oliva G; Cacciola R; Amantia L; Motta L
Minerva Endocrinol; 1987; 12(4):289-300. PubMed ID: 3696102
[No Abstract] [Full Text] [Related]
31. [Insulin therapy with microinfusion devices. Review of the literature].
Bertone V; Locatelli A; Angeli G
Minerva Med; 1987 Jan; 78(2):107-15. PubMed ID: 3808403
[TBL] [Abstract][Full Text] [Related]
32. No sign of amyloidosis in pump-treated diabetics.
Regal H; Koivisto VA; Maury CP; Irsigler K
Diabetes Res; 1988 Aug; 8(4):195-9. PubMed ID: 3069282
[TBL] [Abstract][Full Text] [Related]
33. [Insulin portable pump vs. intensified conventional injections in diabetes].
Gutman RA; Litwak LE; Fagin JA; Plantalech L; Steiner S
Medicina (B Aires); 1985; 45(3):225-30. PubMed ID: 3915900
[No Abstract] [Full Text] [Related]
34. Intensive insulin therapy: euglycemia with a price tag.
Roman SH
Mt Sinai J Med; 1991 Sep; 58(4):305-9. PubMed ID: 1944317
[TBL] [Abstract][Full Text] [Related]
35. [Comparative study between the subcutaneous continuous insulin infusion pump and optimized conventional treatment. Effects at 6 months].
Goicolea Opacua I; Hernández Colau I; Vázquez García JA
Rev Clin Esp; 1986 Jun; 179(1):3-7. PubMed ID: 3526432
[No Abstract] [Full Text] [Related]
36. Diabetic renal-retinal syndrome: does tight control help?
Cowan CL
Transplant Proc; 1987 Apr; 19(2 Suppl 2):86-9. PubMed ID: 3551259
[No Abstract] [Full Text] [Related]
37. Long-term application of wearable artificial endocrine pancreas--closed-loop intravenous vs subcutaneous insulin infusion.
Shichiri M; Kawamori R; Goriya Y; Yamasaki Y; Nomura M; Asakawa N; Kubota M; Kamada T
Life Support Syst; 1985; 3 Suppl 1():583-7. PubMed ID: 3916624
[TBL] [Abstract][Full Text] [Related]
38. [Continuous subcutaneous insulin infusion with portable pumps].
Radermecker RP; Hermans MP; Legrand DA; Scheen AJ
Rev Med Liege; 2005; 60(5-6):329-34. PubMed ID: 16035289
[TBL] [Abstract][Full Text] [Related]
39. [Continuous subcutaneous insulin infusion therapy. Prerequisites, indications and risks].
Sonnenberg GE; Spraul M; Chantelau EA; Berger M
Dtsch Med Wochenschr; 1985 Nov; 110(48):1859-64. PubMed ID: 3933943
[No Abstract] [Full Text] [Related]
40. Long term safety and efficacy of intraperitoneal insulin infusion by means of implantable pumps.
Pinget M; Jeandidier N
Horm Metab Res; 1998 Aug; 30(8):475-86. PubMed ID: 9761375
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
